000 01424 a2200409 4500
005 20250518012140.0
264 0 _c20190606
008 201906s 0 0 eng d
022 _a1573-7365
024 7 _a10.1007/s11011-018-0356-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Song-Yun
245 0 0 _aL-3-n-butylphthalide attenuates cognitive deficits in db/db diabetic mice.
_h[electronic resource]
260 _bMetabolic brain disease
_c02 2019
300 _a309-318 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBenzofurans
_xpharmacology
650 0 4 _aCaspase 3
_xmetabolism
650 0 4 _aCognition
_xdrug effects
650 0 4 _aCognitive Dysfunction
_xdrug therapy
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aDiabetes Mellitus, Type 2
_xcomplications
650 0 4 _aDisease Models, Animal
650 0 4 _aHippocampus
_xdrug effects
650 0 4 _aMaze Learning
_xdrug effects
650 0 4 _aMice
650 0 4 _aNeuroprotective Agents
_xpharmacology
650 0 4 _aOxidative Stress
_xdrug effects
700 1 _aJi, Su-Xiao
700 1 _aBai, Xiao-Mei
700 1 _aYuan, Fang
700 1 _aZhang, Li-Hui
700 1 _aLi, Jie
773 0 _tMetabolic brain disease
_gvol. 34
_gno. 1
_gp. 309-318
856 4 0 _uhttps://doi.org/10.1007/s11011-018-0356-6
_zAvailable from publisher's website
999 _c29120243
_d29120243